ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Baron & Budd Attorney Recognized with National Civil Justice Award

Anna Rol among four honored with inaugural Compassionate Counsel distinction

Baron & Budd, P.C.’s Anna Rol has been named to the 2023 class of Compassionate Counsel honorees. In its inaugural year, this distinction is awarded annually by The Milestone Charitable Foundation to a select group of lawyers across the country who are innovative in their pursuit of justice.

Compassionate Counsel recipients are selected by The Milestone Foundation’s board for their unwavering commitment to the tenets of the Seventh Amendment and belief in the fundamental right to justice. These lawyers work tirelessly to help victims of civil injustices receive their rightful compensation and avoid additional harm or trauma throughout the course of their lawsuit. They see their clients as worthy of respect, see access to fair funding and financial support as a right and look out for their clients’ well-being well beyond settlement.

“When speaking with Anna, her care for her clients and staff is brilliantly apparent,” said Erin Waas, executive director of The Milestone Foundation. “She emphasizes the human aspect of her work in all that she does, and that is exactly what Compassionate Counsel signifies.”

Anna Rol is dedicated to holding pharmaceutical corporations accountable for putting dangerous drugs and devices on the market. She works hard to represent those individuals who have suffered at the hands of pharmaceutical products and gives a powerful voice to medical consumers. Since joining Baron & Budd, Ms. Rol has worked on a variety of pharmaceutical cases, including Transvaginal Mesh, Fluoroquinolone Antibiotics, Xarelto, IVC Filter, Essure, and Talcum litigation.

“I am very honored to be recognized by The Milestone Charitable Foundation,” said Rol. “The work I do every day fighting for individuals harmed by pharmaceutical companies is inherently rewarding, and this recognition reinforces my commitment to seeking justice for those who are injured by pharmaceutical products.”

In addition to Ms. Rol, the 2023 class of Compassionate Counsel honorees includes Ben Whitley of Whitley Law Firm, Kim Dougherty of Justice Law Collaborative, LLC and Ellen Relkin of Weitz & Luxenberg, P.C.

Awardees will be honored at a ceremony January 22, 2023, in Miami. For more information about The Milestone Foundation’s Compassionate Counsel awards, visit https://themilestonefoundation.org/compassionate-counsel/.

About Baron & Budd, P.C.

Baron & Budd, P.C. is among the largest and most accomplished plaintiffs’ law firms in the country. With more than 45 years of experience, Baron & Budd has the expertise and resources to handle complex litigation throughout the United States. As a law firm that takes pride in remaining at the forefront of litigation, Baron & Budd has spearheaded many significant cases for hundreds of entities and thousands of individuals. Since the firm was founded in 1977, Baron & Budd has achieved substantial national acclaim for its work on cutting-edge litigation, trying hundreds of cases to verdict and settling tens of thousands of cases in areas of litigation as diverse and significant as dangerous and highly addictive pharmaceuticals, defective medical devices, asbestos and mesothelioma, California wildfires and environmental contamination, fraudulent banking practices, e-cigarettes, motor vehicles, federal and state whistleblower cases, and other consumer fraud issues.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.41
+0.00 (0.00%)
AAPL  268.47
+0.00 (0.00%)
AMD  233.54
+0.00 (0.00%)
BAC  53.20
+0.00 (0.00%)
GOOG  279.70
+0.00 (0.00%)
META  621.71
+0.00 (0.00%)
MSFT  496.82
+0.00 (0.00%)
NVDA  188.15
+0.00 (0.00%)
ORCL  239.26
+0.00 (0.00%)
TSLA  429.52
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.